ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers
Author(s): Fujimoto J, Ichigo S, Hirose R, Sakaguchi H, Tamaya T
Source: CANCER LETTERS    Volume: 134    Issue: 1    Pages: 15-22    Published: DEC 11 1998  
Times Cited: 29     References: 31     
Abstract: To know the potential of growth, invasion and metastasis of uterine endometrial cancer associated with neovascularization, the expressions of VEGF and its mRNA, especially their subtypes, in uterine endometrial cancers and normal uterine endometria as controls were determined by Western blot analyses with a sandwich enzyme immunoassay and RT-PCR-Southern blot analysis, respectively, and the relation between their expressions and histological grades, grades of myometrial invasion and clinical stages of uterine endometrial cancers was analyzed. The levels of VEGF (VEGF(165) and VEGF(121)) protein and mRNA were in a wide range and higher in normal uterine endometria than in the malignant counterparts. The levels of VEGF protein were higher in order of histopathological differentiation (normal uterine endometrium > well-differentiated (G1) > moderately differentiated (G2) and poorly differentiated (G3)) and those of VEGF protein and VEGF(121) mRNA were lower in order of the advance of clinical stages (normal uterine endometrium > stage I > stage II > stages III and TV). There was, however, no significant difference in their levels among uterine endometrial cancers classified according to grades of myometrial invasion. This suggests that VEGF is downregulated during uterine endometrial cancer progression with dedifferentiation. Namely, VEGF in some endometrial cancers might contribute to the early process of advancing of malignancy via angiogenic activity. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
Document Type: Article
Language: English
Reprint Address: Fujimoto, J (reprint author), Gifu Univ, Sch Med, Dept Obstet & Gynecol, 40 Tsukasa Machi, Gifu 5008705, Japan
Addresses:
1. Gifu Univ, Sch Med, Dept Obstet & Gynecol, Gifu 5008705, Japan
Publisher: ELSEVIER SCI IRELAND LTD, CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND
Subject Category: Oncology
IDS Number: 153XQ
ISSN: 0304-3835
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo